- Author:
Byung Su YOO
1
;
Jeong Seon RYU
;
Won Yeon LEE
;
Kwang Seon SONG
;
Kang Hyun AHN
;
Suk Joong YONG
;
Kye Chul SHIN
;
Young Ju KIM
Author Information
- Publication Type:Original Article
- Keywords: Hemoptysis; Transcatheter arterial embolization
- MeSH: Arteries; Bronchial Arteries; Chest Pain; Fever; Hemoptysis*; Hemorrhage; Humans; Intestinal Pseudo-Obstruction; Lung Diseases; Pulmonary Atelectasis; Pulmonary Disease, Chronic Obstructive; Recurrence
- From:Tuberculosis and Respiratory Diseases 1995;42(1):50-57
- CountryRepublic of Korea
- Language:Korean
- Abstract: BACKGROUND: Transcather arterial embolization has been established as an effective means to control hemoptysis, especially in patients with decreased pulmonary function such as postpneumonectomy patients and those with advanced chronic obstructive pulmonary disease. We evaluated the effect of arterial embolization and analysed the correlation of the clinical and angiographic characteristics and investigated the clinical course and outcome after arterial embolization in the patients with significant hemoptysis. METHOD: 58 patients with massive or recurrent hemoptysis underwent transcatheter arterial embolization for the treatment of hemoptysis from April 1992 to Sept. 1993. RESULTS: Most common cause of hemoptysis was pulmonary tuberculosis(34 cases, 58.3%). Embolized vessels responsible for hemoptysis were 56 bronchial arteries and 32 nonbronchial systemic arteries. Initial most common angiographic findings were hypervascularity and shunt. Initial success rate of hemoptysis control revealed 81.1%. However, 15 of 58 patients(25.9%) showed recurrence of hemoptysis after transcatheter arterial embolization. The complications(18 cases, 31%) such as chest pain, fever, voiding difficulty, atelectasis, paralytic ileus and unwanted embolization were occured. CONCLUSION: Transcatheter arterial embolization is useful and relatively safe treatment modality for immediate bleeding control of patients with massive hemoptysis or inoperable cases. The further evaluation of the long term results according to the embolized material and underlying pulmonary disease will be required.